pneumocystosis
pneumocystosis
Explore linked clinical trials. Standard reference: MONDO:001912115 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia | Bacterial Infections and Mycoses, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pneumocystis infectious disease, Pneumocystis jirovecii Infection, Respiration Disorders, Respiratory Aspiration, fungal infectious disease, fungal lung infectious disease, interstitial lung disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT06892951 | |
| Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score | Bacterial Infections and Mycoses, Community-Acquired Infections, Community-Acquired Pneumonia, Disease Attributes, Emergencies, Infections, Invasive Fungal Infections, Invasive Pulmonary Aspergillosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pneumocystis infectious disease, aspergillosis, coinfection, fungal infectious disease, fungal lung infectious disease, infectious disease, lung disorder, pneumocystosis, pneumonia, pulmonary aspergilloma, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not stated | 2026-07-02 | NCT07681583 | |
| Low- vs Standard-Dose TMP-SMX for Prevention of Pneumocystis Pneumonia After Kidney Transplantation | Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Phase 4 | 2026-06-01 | NCT07619027 | |
| Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients | Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not stated | 2026-04-23 | NCT06890078 | |
| Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDS | AIDS, Bacterial Infections and Mycoses, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, Pneumocystis infectious disease, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, fungal infectious disease, fungal lung infectious disease, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Enrolling by invitation | Not applicable | 2026-03-27 | NCT03856229 | |
| Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia | Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, Pneumocystis jirovecii Infection, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 3 | 2026-02-20 | NCT04851015 | |
| Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives) | Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, Pneumocystis jirovecii Infection, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Phase 4 | 2026-01-21 | NCT07357103 | |
| How Long Should we Give Steroids for Patients With Severe PCP | Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, Pneumocystis jirovecii Infection, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Phase 4 | 2026-01-09 | NCT07328984 | |
| Introduction of Polymerase Chain Reaction (PCR) in Microbiology and Parasitology | Bacterial Infections and Mycoses, Infections, Mosquito-Borne Diseases, Pneumocystis infectious disease, fungal infectious disease, fungal lung infectious disease, lung disorder, malaria, parasitic infectious disease, pneumocystosis, pneumonia, protozoa infectious disease, respiratory system disorder, respiratory tract infectious disorder, vector-borne disease | Recruiting | Not stated | 2025-12-08 | NCT07269314 | |
| Corticosteroids for PJP in Non-HIV Immunocompromised Adults | Bacterial Infections and Mycoses, Community-Acquired Infections, Community-Acquired Pneumonia, Infections, Pneumocystis infectious disease, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Phase 3 | 2025-09-09 | NCT07152613 | |
| Pneumocystis Jirovecii Genotyping | Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Not stated | 2025-06-27 | NCT06442345 | |
| Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults | Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 2 | 2025-04-03 | NCT05835479 | |
| Caspofungin for Pneumocystis Pneumonia in PLWHIV. | Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not stated | 2024-11-19 | NCT06691321 | |
| Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease | Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, fungal infectious disease, fungal lung infectious disease, immune system disorder, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 4 | 2024-10-01 | NCT06499233 | |
| Droplet Digital PCR and PCR-free BIOSensors for the Detection of Resistance-associated SNPs in Pneumocystis Jirovecii | Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Active, not recruiting | Not stated | 2024-08-09 | NCT06431958 |